Mr Garofoli brings a valuable skill set to PainChek as the company accelerates its footprint in the US aged care sector in anticipation of FDA clearance and market entry
I am pretty sure during the recent interviews with the FDA, PD must have been given an indication of how things are travelling. For them to make this move, chances are the FDA is coming soon.
Good luck all.
Ann: PainChek appoints head of Business Development for US market, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.68M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 142370 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.1¢ | 895239 | 2 |
View Market Depth
| Last trade - 07.10am 25/07/2025 (20 minute delay) ? |
| PCK (ASX) Chart |
Day chart unavailable